Peptide mixture
AssigneeTargovax Asa
InventorJon Amund Eriksen
Life of this patent
Estimating the term…
Loading patent…
AssigneeTargovax Asa
InventorJon Amund Eriksen
Estimating the term…
There is disclosed a peptide mixture suitable for eliciting an immune response. It comprises a first and a second peptide, each corresponding to a fragment of the RAS protein. Each of the first and second peptides comprises a region of at least 8 amino acids which includes position 13 of the RAS protein. Each of said regions of the first and second peptides independently has at least 6 amino acid residues, other than at said position 13, which are identical to the corresponding region of the RAS protein. Each of the first and the second peptides has a point mutation at the amino acid corresponding to said position 13. The point mutation of the first peptide is different from the point mutation of the second peptide.
A method of stimulating the immune system to treat or prevent cancer associated with RAS protein amino acid substitutions in a human or animal subject, the method comprising administering to the subject a peptide mixture suitable for eliciting an immune response in a human or animal subject for treating or preventing cancer in the subject, wherein the peptide mixture comprises a first, second and at least one further peptide, each corresponding to a fragment of the RAS protein,
Dependencies are inferred from the claim text.